Impact of the 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene on primary nephrotic syndrome

By      

Molecular Medicine Reports, Vol. 9, Iss. 3, 2014-01 ,pp. : 894-898

Spandidos Publications

Access to resources Recommend Favorite

PAI-1 promoter 4G/5G polymorphism (rs1799768) contributes to tumor susceptibility: Evidence from meta-analysis

By                        

Experimental and Therapeutic Medicine, Vol. 4, Iss. 6, 2012-01 ,pp. : 1127-1133

Spandidos Publications

Access to resources Recommend Favorite

Expression of urokinase plasminogen activator and plasminogen activator inhibitor type-1 in ovarian cancer and its clinical significance

By          

Oncology Reports, Vol. 29, Iss. 2, 2013-01 ,pp. : 637-645

Spandidos Publications

Access to resources Recommend Favorite

Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients

By Chung Hyun   Rha Sun   Park Joon   Yoo Nae   Kim Joo   Roh Jae   Min Jin   Lee Kyong   Kim Byung   Kim Jin  

Breast Cancer Research and Treatment, Vol. 49, Iss. 1, 1998-05 ,pp. : 41-50

Springer Publishing Company

Access to resources Recommend Favorite

The 1438G/A polymorphism of the 5-HT_2A receptor gene is associated with aura in migraine

By Erdal M. Emin   Yilmaz Mustafa   Herken Hasan   Kocoglu Hasan   Bayazit Yildirim A.  

The Pain Clinic, Vol. 15, Iss. 3, 2003-09 ,pp. : 315-319

Maney Publishing

Access to resources Recommend Favorite